Phase I Study of Chemoradiation With Midostaurin (PKC412) For Locally Advanced Rectal Cancer.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Midostaurin (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 20 Jun 2017 Planned End Date changed from 1 Jun 2022 to 1 Mar 2022.
- 20 Jun 2017 Status changed from recruiting to active, no longer recruiting.